Skip to main content
SpringerLink
Log in

History of Urticaria

  • Chapter
Book cover Urticaria and Angioedema

Core Messages

  • The beginning of the twentieth century ushered in the era of molecular medicine, eventually leading to unravelling of the molecular and immunological basis of urticaria.

  • The mast cell and its histamine content remain central to the pathophysiology of the pruritic wheal in most forms of urticaria, and the synthesis, storage,regulation of release of histamine as well as molecular characterisation of its receptors are becoming well understood.

  • The challenge of the past 50 years has been to understand the causation of the promiscuous activation of dermal and mucosal mast cells in idiopathic chronic urticaria and angioedema.

  • The discovery in the 1980s of autoreactivity in the serum of some patients with chronic urticaria (the autologous serum skin test) was a major step forward and prompted attempts to identify and characterise this activity.

  • The subsequent finding in chronic urticaria of specific complement-dependent autoantibodies, which release histamine and other mediators from mast cells and basophils via dimerisation of their high affinity IgE receptors, has stimulated intense interest in the multifactorial modes of activation of mast cells and basophils in this disorder.

  • Antihistamines, discovered in the 1940s, remain the cornerstone of treatment of most types of urticaria. Although recent derivative (“second-generation”) compounds manifest greatly refined properties, they are often only moderately effective.

  • New therapeutic approaches “round the corner” include bradykinin B2 antagonists (for angioedema) and the anti-IgE immunobiologic omalizumab

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Czarnetzki BM. History of urticaria. Int J Dermatol. 1989;28:52–7

    Article  PubMed  CAS  Google Scholar 

  2. Humphreys F. Major landmarks in the history of urticarial disorders. Int J Dermatol. 1997;36:793–96

    Article  PubMed  CAS  Google Scholar 

  3. Ehrlich P. Beitrage zur Kenntnis der Anilinfarbungen und ihrer in der Verwendung mikrosko-pischen Technik. Arch Mikr-Anat. 1877;13:263–77

    Article  Google Scholar 

  4. Riley JF. The mast cells. Chapter 16: Mast cells and histamine in the skin. Edinburgh: E&S Livingstone, 1959. p. 144–59

    Google Scholar 

  5. Dale HH. On some physiological actions of ergot. J Physiol. 1906;34:163–206

    PubMed  Google Scholar 

  6. Greaves MW, Sabroe RA. Histamine: the quintessential mediator. J Dermatol. 1996;23:735–40

    PubMed  CAS  Google Scholar 

  7. Lewis T. The blood vessels of the human skin and their responses. London: Shaw; 1927

    Google Scholar 

  8. Simone DA, Alreja M, La Motte RH. Psychophysical studies of the itch sensation and itchy skin (alloknesis) produced by intacutaneous injection of histamine. Somatosens Mot Res. 1991;8:271–79

    Article  PubMed  CAS  Google Scholar 

  9. Le Coniat M, Traiffort E, Ruat M, Arrang J-M, Berger R. Chromosomal localisation of the human histamine H1 receptor gene. Hum Genet. 1994;94:186–8

    Article  PubMed  Google Scholar 

  10. Gantz I, Schaffer M, DelValle J, et al Molecular cloning of the gene encoding the histamine H2 receptor. Proc Nat Acad Sci USA. 1991; 88:429–33

    Article  PubMed  CAS  Google Scholar 

  11. O’Leary PA, Farber EM. Benadryl in the treatment of certain diseases of the skin. J Am Med Assoc 1947;134:1010–13

    Article  PubMed  Google Scholar 

  12. Bain WA, Hellier FF, Warin RP. Some aspects of the action of histamine antagonists. Lancet 1948;2:964–69

    Article  PubMed  CAS  Google Scholar 

  13. Fung-Leung W-P, Thurmond RL, Ling P, Karlsson L. Histamie H4 antagonists: the new anti-histamines ? Curr Opin Invest New Drugs. 2004;5:1174–80

    CAS  Google Scholar 

  14. Kaplan AP, Horakova, Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol. 1978;61:350–54

    Article  PubMed  CAS  Google Scholar 

  15. Okahara K, Murakami T, Yamamoto S, Yata N. Skin microdialysis. Detection of in vivo hista-mine release in cutaneous allergic reactions. Skin Pharmacol. 1995;8:113–18

    Article  PubMed  CAS  Google Scholar 

  16. Cook J, Shuster S. Histamine wheal formation and absorption in Man. Br J Pharmacol. 1980; 69:579–85

    Article  PubMed  CAS  Google Scholar 

  17. Ishizaka, K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody: correlation of reaginic antibody with γE antibody. J Immunol. 1966;97:840–53

    PubMed  CAS  Google Scholar 

  18. Gell PGH, Coombs RR. Clinical aspects of immunology. Oxford: Blackwell; 1963. p. 317–20

    Google Scholar 

  19. Michaelsson G, Juhlin L. Urticaria inuced by preservatives and dye additives in food and drugs. Br J Dermatol. 1973;88:525–32

    Article  PubMed  CAS  Google Scholar 

  20. Doeglas HMG. Reactions t aspirin and food additives in patients with chronic urticaria including the physical urticarias. Br J Dermatol. 1975;93:135–44

    Article  PubMed  CAS  Google Scholar 

  21. Supramanian G, Warner JO. Artificial food additive intolerance in patients with angioedema and urticaria. Lancet 1986;2:907–10

    Article  Google Scholar 

  22. Zuberbier T, Chantraine-Hess S, Hartman K, Czarnetzki BM. Pseudoallergen free diet in the treatment of chronic urticaria—a prospective study. Acta Dermato-vener (Stockh). 1995;75:484–87

    CAS  Google Scholar 

  23. Greaves M. Food Intolerance in urticaria and angioedema and urticarial vasculitis. In Food Allergy and Intolerance 2nd Ed. 2002; Brostoff J, Challacombe S, Eds, Philadelphia: WB Saunders. P623–69

    Google Scholar 

  24. Burova GP, Mallet AI, Greaves MW. Is Helicobacter pylori a cause of chronic urticaria. Br J Dermatol. 1998;139 Suppl 51:42

    Google Scholar 

  25. Greaves MW. Chronic idiopathic urticaria and Helicobacter pylori: not directly related—but could there be a link? ACI Int 2001;13:23–6

    Google Scholar 

  26. Rorsman H. Basophilic leucopenia in different forms of urticaria. Acta Allergologica. 1962;17:168–84

    PubMed  CAS  Google Scholar 

  27. Greaves MW, Plummer VM, Mc Laughlan P, Stanworth DR. Serum and cell bound IgE in chronic urticaria. Clin Allergy. 1974;4:265–71

    Article  PubMed  CAS  Google Scholar 

  28. Gruber BL, Baeza ML, Marchese MJ, et al Prevalence and functional role of anti-IgE autoan-tibodies in urticarial syndromes. J Invest Dermatol. 1988; 90:213–17

    Article  PubMed  CAS  Google Scholar 

  29. Leznoff A, Sussman GL. Syndrome of idiopathic urticaria and angioedema with thyroid auto-immunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84:66–71

    Article  PubMed  CAS  Google Scholar 

  30. O’Donnell BF, O’Neill CM, Francis DM, et al Human leucocyte class 11 associations in chronic idiopathic urticaria. Br J Dermatol. 1999;140:853–88

    Article  PubMed  Google Scholar 

  31. Grattan CEH, Wallington TB, Warin RP, et al A serological mediator in chronic idiopathic urticaria—a clinical immunological and histological evaluation. Br J Dermatol.1986;114:583–90

    Article  PubMed  CAS  Google Scholar 

  32. Claveau J, Lavoie A, Brunet C, et al Chronic idiopathic urticaria: possible contribution of histamine –releasing factor to pathogenesis. J Allergy Clin Immunol.1993;92:132–37

    Article  PubMed  CAS  Google Scholar 

  33. MacDonald SM, Rafnar T, Langdon J, Lichtenstein SM. Molecular identification of an IgE-dependent histamine releasing factor. Science 1995;269:688–70

    Article  PubMed  CAS  Google Scholar 

  34. Hide M, Francis DM, Grattan CEH, et al Autoantibodies against the high affinity IgE receptor as a cause for histamine release in chronic urticaria. N Eng J Med. 1993;328:1599–604

    Article  CAS  Google Scholar 

  35. Nimii N, Francis DM, Kermani F, et al Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol. 1996; 106:1001–10

    Article  Google Scholar 

  36. Fiebiger E, Maurer D, Holub H, et al Serum IgG autoantibodies directed against the alpha—chain of FcεR1; a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients. J Clin Invest.1995;96:2606–12

    Article  PubMed  CAS  Google Scholar 

  37. Tong LJ, Balakrishnan G, Kochan JP, et al Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol.1997; 99:461–65

    Article  PubMed  CAS  Google Scholar 

  38. Grattan CEH, Francis DM. Autoimmune urticaria. Adv Dermatol. 1999;15:311–40

    Google Scholar 

  39. Staub A, Bovet D. Actions de la thymoethyl-diethylamine (929F) et des ethersphenoliques sur le choc anaphylactique du cobaye. CR Soc Biol. 1937;128:818–25

    Google Scholar 

  40. Leurs R, Church MK, Taglialatela M. H1 antihistamines: inverse agonism. Anti—inflammatory effects and cardiac effects. Clin Exp Allergy. 2002;32:489–98

    Article  PubMed  CAS  Google Scholar 

  41. Marks R, Greaves MW. Vascular reactions to histamine and compound 48/80 in human skin: suppression by an H2 receptor blocking agent. Br J Clin Pharmacol. 1977;4:367–69

    Article  PubMed  CAS  Google Scholar 

  42. Bleehen SS, Thomas SE, Greaves MW, et al Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria. Br J Dermatol. 1987; 117:81–8

    Article  PubMed  CAS  Google Scholar 

  43. Simons FER, Simons KJ. The pharmacology and use of H1 receptor antagonist drugs. N Eng J Med. 1994;330:1663–70

    Article  CAS  Google Scholar 

  44. Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother. 1996;30:1075–79

    PubMed  CAS  Google Scholar 

  45. Finn AF, Kaplan AP, Fretwell R, et al A double-blind placebo-controlled trial of fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999; 10:1071–78

    Article  PubMed  CAS  Google Scholar 

  46. Paul E, Berth-Jones J, Ortonne J-P, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: a placebo—controlled parallel group, dose ranging study. J Dermatol Treat. 1998;9:143–49

    Article  CAS  Google Scholar 

  47. Zuberbier T, Munzberger C, Haustein U, et al Double—blind crossover study of high dose ceti-rizine in cholinergic urticaria. Dermatology 1996;193:324–37

    Article  PubMed  CAS  Google Scholar 

  48. Di Lorenzo G, Pacor ML, Mansueto P, et al Randomised placebo-controlled trial comparing deslratidine and montelukast in monotherapy and desloratidine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol. 2004;114:619–25

    Article  PubMed  Google Scholar 

  49. Yamashita M, Fukui H, Sugama K, et al Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc Natl Acad Sci USA. 1991;88:115–19

    Article  Google Scholar 

  50. Zuberbier T, Bindslev-Jensen C, Canonica W, et al EAACI/GA2LEN/EDF guideline: defini-tion, classification and diagnosis of urticaria. Allergy 2006;61:321–31

    Article  PubMed  CAS  Google Scholar 

  51. Zuberbier T, Bindslev-Jensen C, Canonica W, et al EAACI/GA2LEN guideline: management of urticaria. Allergy 2006;61:316–20

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cutaneous Allergy Clinic, St. Johns Institute of Dermatology, St. Thomas Hospital, London, SE1 7EH, UK

    M Greaves

Authors
  1. M Greaves
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Greaves .

Editor information

Editors and Affiliations

  1. Department of Dermatology and Allergy Allergy-centre-Charité, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany

    Torsten Zuberbier (Prof. Dr. med.) & Marcus Maurer (Prof. Dr. med.) (Prof. Dr. med.) &  (Prof. Dr. med.)

  2. Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, NR4 7UY, United Kingdom

    Clive E. H. Grattan MA, MD, FRCP

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Greaves, M. (2010). History of Urticaria. In: Zuberbier, T., Grattan, C.E.H., Maurer, M. (eds) Urticaria and Angioedema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79048-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79048-8_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79047-1

  • Online ISBN: 978-3-540-79048-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation